276 related articles for article (PubMed ID: 25569375)
1. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
2. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.
Keikhaei B; Mohseni AR; Norouzirad R; Alinejadi M; Ghanbari S; Shiravi F; Solgi G
Eur Cytokine Netw; 2013 Mar; 24(1):45-52. PubMed ID: 23608554
[TBL] [Abstract][Full Text] [Related]
3. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
Musa BO; Onyemelukwe GC; Hambolu JO; Mamman AI; Isa AH
Clin Vaccine Immunol; 2010 Apr; 17(4):602-8. PubMed ID: 20130127
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
6. The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease.
Mohammed FA; Mahdi N; Sater MA; Al-Ola K; Almawi WY
Blood Cells Mol Dis; 2010 Dec; 45(4):293-6. PubMed ID: 20813565
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
[TBL] [Abstract][Full Text] [Related]
8. The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease.
Al-Habboubi HH; Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Almawi WY
Eur J Haematol; 2012 Nov; 89(5):403-9. PubMed ID: 22925497
[TBL] [Abstract][Full Text] [Related]
9. Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients.
Silva-Junior AL; Garcia NP; Cardoso EC; Dias S; Tarragô AM; Fraiji NA; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; De Paula EV; Costa AG; Malheiro A
Front Immunol; 2021; 12():559925. PubMed ID: 33776989
[TBL] [Abstract][Full Text] [Related]
10. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises.
Barbu EA; Mendelsohn L; Samsel L; Thein SL
Cytokine; 2020 Mar; 127():154933. PubMed ID: 31778959
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
13. Anti-annexin V IgG and IgM antibodies in sickle cell disease patients with vaso-occlusive crisis.
Sater MS; Mahdi N; Al-Absi IK; Al-Subaie AM; Al-Ola K; Mohammed FA; Almawi WY
Ann Hematol; 2011 Sep; 90(9):1031-6. PubMed ID: 21340721
[TBL] [Abstract][Full Text] [Related]
14. Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients.
Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Al-Ola K; Almawi WY
Ann Hematol; 2012 Aug; 91(8):1215-20. PubMed ID: 22576309
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease.
Gonçalves MS; Queiroz IL; Cardoso SA; Zanetti A; Strapazoni AC; Adorno E; Albuquerque A; Sant'Ana A; dos Reis MG; Barral A; Barral Netto M
Braz J Med Biol Res; 2001 Oct; 34(10):1309-13. PubMed ID: 11593306
[TBL] [Abstract][Full Text] [Related]
16. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Elshazly SA; Heiba NM; Abdelmageed WM
Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
[TBL] [Abstract][Full Text] [Related]
17. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Al Najjar S; Adam S; Ahmed N; Qari M
Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
[TBL] [Abstract][Full Text] [Related]
18. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
Setty BN; Chen D; Stuart MJ
Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
